Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
11:26 EDT 7 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
SOLANA BEACH, Calif., Aug. 7, 2012 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (OTC Markets Group: IMMY), a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has created a Science and Regul...
Other Sources for this Article
More From BioPortfolio on "Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
